Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands.


Journal

Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 14 02 2018
revised: 10 04 2018
accepted: 04 05 2018
pubmed: 19 7 2018
medline: 12 3 2020
entrez: 19 7 2018
Statut: ppublish

Résumé

Computed tomography (CT), a strong diagnostic tool, delivers higher radiation doses than most imaging modalities. As CT use has increased rapidly, radiation protection is important, particularly among children. We evaluate leukemia and brain tumor risk following exposure to low-dose ionizing radiation from CT scans in childhood. For a nationwide retrospective cohort of 168 394 children who received one or more CT scans in a Dutch hospital between 1979 and 2012 who were younger than age 18 years, we obtained cancer incidence, vital status, and confounder information by record linkage with external registries. Standardized incidence ratios were calculated using cancer incidence rates from the general Dutch population. Excess relative risks (ERRs) per 100 mGy organ dose were calculated with Poisson regression. All statistical tests were two-sided. Standardized incidence ratios were elevated for all cancer sites. Mean cumulative bone marrow doses were 9.5 mGy at the end of follow-up, and leukemia risk (excluding myelodysplastic syndrome) was not associated with cumulative bone marrow dose (44 cases). Cumulative brain dose was on average 38.5 mGy and was statistically significantly associated with risk for malignant and nonmalignant brain tumors combined (ERR/100 mGy: 0.86, 95% confidence interval = 0.20 to 2.22, P = .002, 84 cases). Excluding tuberous sclerosis complex patients did not substantially change the risk. We found evidence that CT-related radiation exposure increases brain tumor risk. No association was observed for leukemia. Compared with the general population, incidence of brain tumors was higher in the cohort of children with CT scans, requiring cautious interpretation of the findings.

Sections du résumé

BACKGROUND
Computed tomography (CT), a strong diagnostic tool, delivers higher radiation doses than most imaging modalities. As CT use has increased rapidly, radiation protection is important, particularly among children. We evaluate leukemia and brain tumor risk following exposure to low-dose ionizing radiation from CT scans in childhood.
METHODS
For a nationwide retrospective cohort of 168 394 children who received one or more CT scans in a Dutch hospital between 1979 and 2012 who were younger than age 18 years, we obtained cancer incidence, vital status, and confounder information by record linkage with external registries. Standardized incidence ratios were calculated using cancer incidence rates from the general Dutch population. Excess relative risks (ERRs) per 100 mGy organ dose were calculated with Poisson regression. All statistical tests were two-sided.
RESULTS
Standardized incidence ratios were elevated for all cancer sites. Mean cumulative bone marrow doses were 9.5 mGy at the end of follow-up, and leukemia risk (excluding myelodysplastic syndrome) was not associated with cumulative bone marrow dose (44 cases). Cumulative brain dose was on average 38.5 mGy and was statistically significantly associated with risk for malignant and nonmalignant brain tumors combined (ERR/100 mGy: 0.86, 95% confidence interval = 0.20 to 2.22, P = .002, 84 cases). Excluding tuberous sclerosis complex patients did not substantially change the risk.
CONCLUSIONS
We found evidence that CT-related radiation exposure increases brain tumor risk. No association was observed for leukemia. Compared with the general population, incidence of brain tumors was higher in the cohort of children with CT scans, requiring cautious interpretation of the findings.

Identifiants

pubmed: 30020493
pii: 5046626
doi: 10.1093/jnci/djy104
pmc: PMC6657440
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-263

Subventions

Organisme : Worldwide Cancer Research
ID : 12-1155
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

BMJ. 2000 Mar 4;320(7235):593-4
pubmed: 10698858
Int J Epidemiol. 2006 Apr;35(2):370-84
pubmed: 16308412
Radiat Res. 2006 Oct;166(4):618-28
pubmed: 17007558
Radiat Res. 2007 Jul;168(1):1-64
pubmed: 17722996
Pediatr Radiol. 2011 Jul;41(7):832-8
pubmed: 21594548
Int J Cancer. 2012 Jun 15;130(12):2981-9
pubmed: 21792900
Radiat Prot Dosimetry. 2011 Sep;147(1-2):317-20
pubmed: 21831868
Br J Cancer. 2011 Nov 22;105(11):1783-7
pubmed: 22027710
Radiat Prot Dosimetry. 2012 Jul;150(4):415-26
pubmed: 22228685
BMC Health Serv Res. 2012 Jan 27;12:24
pubmed: 22283843
Lancet. 2012 Aug 4;380(9840):499-505
pubmed: 22681860
Lancet. 2012 Nov 17;380(9855):1736; author reply 1736-7
pubmed: 23158245
BMJ. 2013 May 21;346:f2360
pubmed: 23694687
JAMA Pediatr. 2013 Aug 1;167(8):700-7
pubmed: 23754213
Br J Cancer. 2014 Apr 29;110(9):2354-60
pubmed: 24569470
J Radiol Prot. 2014 Mar;34(1):E1-5
pubmed: 24594968
Eur J Epidemiol. 2014 Apr;29(4):293-301
pubmed: 24748424
Br J Cancer. 2015 Jan 6;112(1):185-93
pubmed: 25314057
Radiat Environ Biophys. 2015 Mar;54(1):1-12
pubmed: 25567615
Ann ICRP. 2015 Jun;44(1 Suppl):236-48
pubmed: 25816281
J Radiol Prot. 2015 Sep;35(3):611-28
pubmed: 26226081
J Radiol Prot. 2015 Dec;35(4):891-909
pubmed: 26609995
Br J Radiol. 2016;89(1060):20150305
pubmed: 26864156
Br J Cancer. 2016 Feb 16;114(4):388-94
pubmed: 26882064
Eur Radiol. 2017 Jun;27(6):2426-2433
pubmed: 27709278
Br J Cancer. 1989 Jan;59(1):100-5
pubmed: 2788005
J Radiol Prot. 2016 Dec;36(4):953-974
pubmed: 27893452
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2575-2583
pubmed: 28323979
Eur J Cancer. 2017 Dec;87:38-46
pubmed: 29107860
IARC Sci Publ. 1987;(82):1-406
pubmed: 3329634
Int J Epidemiol. 1998 Aug;27(4):579-86
pubmed: 9758110

Auteurs

Johanna M Meulepas (JM)

Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Cécile M Ronckers (CM)

Department of Paediatric Oncology, Emma Children's Hospital, University Medical Center Utrecht, the Netherlands.

Anne M J B Smets (AMJB)

Department of Radiology, University Medical Center Utrecht, the Netherlands.

Rutger A J Nievelstein (RAJ)

Department of Radiology, University Medical Center Utrecht, the Netherlands.

Patrycja Gradowska (P)

Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Choonsik Lee (C)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD.

Andreas Jahnen (A)

Luxembourg Institute of Science and Technology (LIST), Esch-sur-Alzette, Luxembourg, the Netherlands.

Marcel van Straten (M)

Department of Radiology and Nuclear Medicine, Erasmus MC Rotterdam, the Netherlands.

Marie-Claire Y de Wit (MY)

Department of Neurology and Paediatric Neurology, Erasmus MC, Sophia Children's Hospital, Rotterdam, the Netherlands.

Bernard Zonnenberg (B)

Department of Internal Medicine, University Medical Center Utrecht, the Netherlands.

Willemijn M Klein (WM)

Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Johannes H Merks (JH)

Department of Paediatric Oncology, Emma Children's Hospital, University Medical Center Utrecht, the Netherlands.
Academic Medical Center Amsterdam, Amsterdam, the Netherlands; Dutch Childhood Oncology Group, the Hague, the Netherlands, University Medical Center Utrecht, the Netherlands.

Otto Visser (O)

Department of Registration, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.

Flora E van Leeuwen (FE)

Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Michael Hauptmann (M)

Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH